BillionToOne, Inc. Class A Common Stock (BLLN) Stock Analysis
$BLLN · HEALTHCARE · DIAGNOSTICS & RESEARCH · NASDAQ
BillionToOne, Inc. Class A Common Stock (BLLN), a DIAGNOSTICS & RESEARCH company, is listed on NASDAQ, has a market capitalization of about $5.31B and trades at 143.0x trailing earnings.
Price
$112.61
Market cap
$5.31B
P/E ratio
143.0x
Dividend yield
—
About BillionToOne, Inc. Class A Common Stock
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company is headquartered in Menlo Park, California.
How StockWorthy values BLLN
StockWorthy forecasts BillionToOne, Inc. Class A Common Stock's revenue, operating profitability, reinvestment (capital expenditure, depreciation and working capital) and unlevered free cash flow, then discounts those cash flows using a normalized cost of capital built from BLLN's size, profitability and balance-sheet risk. Terminal growth is adjusted to reflect the company's mature growth profile rather than a fixed number. The model presents bear, base and bull scenarios, and every key assumption stays transparent and adjustable in the full StockWorthy analysis. Results are educational and not investment advice.
Related stocks
See BLLN's Fair Value
Create a free account to view BillionToOne, Inc. Class A Common Stock's base-case fair value, the bear–bull modeled range, and every assumption behind them. Free accounts include 5 stock valuations per month — plus Advanced DCF models, financial charts, dividends, and peer analysis.